From: CIN III lesions and regression: retrospective analysis of 635 cases
Biopsy-cone interval | ||||
---|---|---|---|---|
<6.1 Weeks | 6.14–12 Weeks | >12 Weeks | Total | |
HPV 16+ | ||||
≤ CIN I | 0 | 0 | 0 | 0 |
CIN II | 4 (5.8 %) | 2 (3.1 %) | 6 (9.4 %) | 12 (6.1 %) |
CIN III | 65 (94.2 %) | 62 (96.2 %) | 58 (90.6 %) | 185 (93.9 %) |
Total | 100 | 175 | 255 | 197 |
HPV-HR pos. but HPV16 neg | ||||
≤ CIN I | 0 | 1 (2.1 %) | 2 (4.4 %) | 3 (2.0 %) |
CIN II | 2 (3.6 %) | 3 (6.3 %) | 5 (11.1 %) | 10 (6.8 %) |
CIN III | 53 (96.4 %) | 44 (91.7 %) | 38 (84.4 %) | 135 (91.2 %) |
Total | 55 | 48 | 45 | 148 |